Login
Super Investors Vivo Capital, LLC
VC

Vivo Capital, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$909M
Positions
50
Quarter ended
September 30, 2026
Filed
November 13, 2026

Reported portfolio value by quarter (43 quarters reported)

$2.85B $303M
Q1 16 Q2 18 Q3 20 Q4 22 Q1 25 Q3 26

$399M in Q1 2016 → $909M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Praxis Precision Medicines 8.7% Unchanged 271,116 $79M
Trevi Therapeutics Inc 6.7% Trimmed 17% 4,229,683 $60.6M
Erasca Inc 6.5% Trimmed 2.6% 4,020,619 $58.9M
Arrivent Biopharma Inc 6.0% Added 6.2% 1,787,104 $54.1M
AS Abivax Sa 4.5% Unchanged 414,899 $41.1M
Entera Bio Ltd 3.9% New 12,254,901 $35.7M
Aclaris Therapeutics Inc 3.9% Unchanged 6,694,637 $35.2M
Alto Neuroscience Inc 3.8% Added 12% 1,359,915 $34.7M
Tango Therapeutics Inc 3.8% Unchanged 1,379,769 $34.4M
Corvus Pharmaceuticals Inc 3.6% Unchanged 2,805,816 $32.3M
Lb Pharmaceuticals Inc 3.4% Unchanged 800,000 $30.7M
Korsana Biosciences Inc 3.1% New 877,020 $28.1M
BT Blossomhill Therapeutics Inc 3.1% New 1,493,740 $27.8M
Faeth Therapeutics Inc 2.8% Added 17% 844,576 $25.1M
Camp4 Therapeutics Corporation 2.5% Added 31% 5,584,111 $22.6M
AL Achieve Life Science Inc 2.4% Unchanged 2,751,032 $22.3M
Sab Biotherapeutics Inc 2.4% Trimmed 5.3% 6,915,011 $21.9M
DT Dbv Technologies Sa 2.4% Unchanged 1,844,758 $21.7M
Bright Minds Biosciences Inc 2.3% Trimmed 25% 417,879 $20.8M
Design Therapeutics Inc 2.2% Unchanged 1,612,903 $20.3M
An2 Therapeutics Inc 1.8% Unchanged 3,153,640 $16.8M
Moonlake Immunotherapeutics 1.8% Unchanged 1,400,000 $16.4M
Minerva Neurosciences Inc 1.6% Unchanged 4,322,747 $14.5M
Odyssey Therapeutics Inc 1.4% Unchanged 575,000 $12.8M
Oric Pharmaceuticals Inc 1.4% Trimmed 50% 924,392 $12.5M
Eupraxia Pharmaceuticals Inc 1.4% Unchanged 1,350,000 $12.3M
Vor Biopharma Inc 1.2% New 550,358 $10.5M
Editas Medicine Inc 1.0% Unchanged 3,555,250 $9.14M
Surrozen Inc 0.9% Unchanged 260,000 $8.37M
Dyne Therapeutics Inc 0.9% Trimmed 67% 514,402 $8.29M
Aura Biosciences Inc 0.8% Unchanged 1,166,667 $7.33M
Cue Biopharma Inc 0.8% New 280,057 $7.25M
Monopar Therapeutics Inc 0.8% Unchanged 90,500 $7.21M
Satellos Bioscience Inc 0.8% Unchanged 813,666 $6.92M
Olema Pharmaceuticals Inc 0.6% Unchanged 671,843 $5.8M
Pepgen Inc 0.6% Unchanged 2,325,000 $5.63M
Onkure Therapeutics Inc 0.6% Unchanged 1,927,710 $5.25M
AT Attovia Therapeutics Inc 0.6% New 300,000 $5.14M
Adarx Pharmaceuticals Inc 0.6% New 255,158 $5.09M
Tenax Therapeutics Inc 0.5% Unchanged 2,500,000 $4.73M
Valneva Se 0.5% Unchanged 763,199 $4.72M
Avalo Therapeutics Inc 0.5% Unchanged 275,000 $4.22M
Compass Therapeutics Inc 0.4% Trimmed 56% 3,423,547 $3.56M
Sera Prognostics Inc 0.4% Unchanged 1,650,440 $3.45M
Instil Bio Inc 0.2% Unchanged 292,743 $2.12M
Inmed Pharmaceuticals Inc 0.1% Added 3.3% 824,874 $1.12M
Bolt Biotherapeutics Inc 0.0% Unchanged 72,414 $266K
Pasithea Therapeutics Corp 0.0% Trimmed 20% 372,796 $184K
Precision Biosciences Inc 0.0% Unchanged 4,675 $29.3K
Jasper Therapeutics Inc 0.0% New 5,364 $3.69K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 13, 2026

Company Action Shares changed Value of change % of portfolio
SB Sinovac Biotech Ltd. Exited −5,903,000 −$38.2M —
Entera Bio Ltd New +12,254,901 +$35.7M 3.9%
Dianthus Therapeutics Inc Exited −353,998 −$34.5M —
Korsana Biosciences Inc New +877,020 +$28.1M 3.1%
BT Blossomhill Therapeutics Inc New +1,493,740 +$27.8M 3.1%
Dyne Therapeutics Inc Trimmed −1,043,064 −$16.8M 0.9%
Oric Pharmaceuticals Inc Trimmed −924,394 −$12.5M 1.4%
Trevi Therapeutics Inc Trimmed −864,985 −$12.4M 6.7%
Geron Corp Exited −8,671,797 −$11.1M —
Vor Biopharma Inc New +550,358 +$10.5M 1.2%

Showing the 10 largest of 26 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
Erasca Inc Trimmed −8,024,068 −$147M 6.9%
Terns Pharmaceuticals Inc Exited −1,334,418 −$70.4M —
Tenax Therapeutics Inc Added +2,291,667 +$33.3M 3.3%
Arrivent Biopharma Inc Added +796,181 +$27.7M 5.3%
Tango Therapeutics Inc Trimmed −775,011 −$24.2M 3.9%
AS Abivax Sa - ADR Added +175,360 +$23.4M 5.0%
Praxis Precision Medicines Trimmed −67,779 −$22.7M 8.3%
Veradermics Inc Exited −300,000 −$18.9M —
Achieve Life Sciences Inc. New +2,751,032 +$18M 1.6%
Cogent Biosciences Inc Exited −422,300 −$16.3M —

Showing the 10 largest of 27 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 20, 2026

Company Action Shares changed Value of change % of portfolio
Terns Pharmaceuticals Inc Trimmed −4,012,510 −$212M 5.8%
Cidara Therapeutics, Inc. Exited −956,670 −$211M —
Cogent Biosciences Inc Trimmed −1,976,693 −$76.1M 1.4%
AP Avadel Pharmaceuticals PLC Exited −2,684,109 −$57.8M —
Erasca Inc Added +2,878,052 +$46.6M 16.3%
Zenas Biopharma Inc Exited −853,495 −$31M —
Geron Corp Trimmed −18,553,495 −$27.6M 1.1%
Sensei Biotherapeutics Inc New +722,020 +$22.8M 1.9%
Arrivent Biopharma Inc New +885,916 +$20.4M 1.7%
Soleno Therapeutics Inc Trimmed −600,000 −$20.1M 0.8%

Showing the 10 largest of 31 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 13, 2026

Company Action Shares changed Value of change % of portfolio
Verona Pharma PLC Exited −1,393,432 −$149M —
Cidara Therapeutics, Inc. Trimmed −354,755 −$78.4M 13.7%
Soleno Therapeutics Inc Trimmed −1,383,294 −$64M 2.7%
Terns Pharmaceuticals Inc Trimmed −1,548,818 −$62.6M 14.0%
Praxis Precision Medicines Added +130,000 +$38.3M 6.3%
Tourmaline Bio Inc. Exited −591,882 −$28.3M —
DT Dbv Technologies Sa Added +1,407,120 +$27M 3.1%
Olema Pharmaceuticals Inc Trimmed −834,019 −$20.9M 1.1%
Akero Therapeutics Inc Exited −434,689 −$20.6M —
Rezolute Inc Exited −2,112,432 −$19.9M —

Showing the 10 largest of 27 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
Soleno Therapeutics Inc Trimmed −1,680,091 −$114M 12.4%
AS Abivax Sa - ADR New +359,305 +$30.5M 2.5%
Cogent Biosciences Inc Added +1,666,666 +$23.9M 3.2%
Sab Biotherapeutics Inc New +11,420,000 +$23M 1.8%
Dyne Therapeutics Inc Added +1,500,000 +$19M 2.7%
Bright Minds Biosciences Inc Added +250,045 +$15.2M 2.4%
Dianthus Therapeutics Inc New +353,998 +$13.9M 1.1%
Lb Pharmaceuticals Inc New +800,000 +$12.6M 1.0%
Compass Therapeutics Inc Added +3,502,000 +$12.3M 2.7%
Camp4 Therapeutics Inc New +3,921,568 +$11.8M 0.9%

Showing the 10 largest of 23 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
Soleno Therapeutics Inc Trimmed −500,000 −$41.9M 33.9%
SB Sinovac Biotech Ltd. New +5,903,000 +$38.2M 3.9%
Cidara Therapeutics, Inc. Added +627,149 +$30.5M 6.5%
Cytomx Therapeutics Inc New +5,769,230 +$13.1M 1.3%
Akero Therapeutics Inc Added +233,521 +$12.5M 2.4%
Oric Pharmaceuticals Inc Added +1,046,154 +$10.6M 3.2%
DT Dbv Technologies Sa New +1,054,506 +$9.66M 1.0%
Praxis Precision Medicines New +167,600 +$7.05M 0.7%
Unicycive Therapeutics Exited −11,370,152 −$6.54M —
Compass Therapeutics Inc Added +2,487,443 +$6.47M 1.6%

Showing the 10 largest of 21 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 12, 2025

Company Action Shares changed Value of change % of portfolio
Soleno Therapeutics Inc Trimmed −1,833,557 −$131M 42.2%
Verona Pharma PLC Trimmed −845,190 −$53.7M 12.1%
Delcath Systems, Inc. Trimmed −958,384 −$12.2M 1.3%
Akero Therapeutics Inc New +201,168 +$8.14M 1.1%
CP Compass Pathway PLC Added +1,754,385 +$5.02M 1.3%
Oric Pharmaceuticals Inc Added +802,632 +$4.48M 1.5%
Regulus Therapeutics Inc Trimmed −2,303,574 −$4.03M 0.6%
Surrozen Inc New +260,000 +$3.03M 0.4%
89bio Inc New +376,804 +$2.74M 0.4%
Rezolute Inc Trimmed −685,272 −$1.99M 0.8%

Showing the 10 largest of 17 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 13, 2025

Company Action Shares changed Value of change % of portfolio
Harmony Biosciences Holdings Inc Exited −2,606,247 −$104M —
SB Sinovac Biotech Ltd. Exited −11,800,000 −$76.3M —
Verona Pharma PLC Trimmed −1,265,783 −$58.8M 11.9%
Aclaris Therapeutics, Inc. New +8,888,888 +$22M 2.5%
Cidara Therapeutics, Inc. New +670,600 +$18M 2.0%
VT Viridian Therapeutics Inc Trimmed −695,631 −$13.3M 2.1%
Bright Minds Biosciences Inc New +251,572 +$9.06M 1.0%
Delcath Systems, Inc. Added +711,574 +$8.57M 2.3%
Trevi Therapeutics Inc Added +1,875,000 +$7.73M 1.6%
Alx Oncology Holdings Inc Exited −4,034,522 −$7.34M —

Showing the 10 largest of 18 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support